Q2 2024 |
40 |
$184M |
+$55.4M |
-$47.9M |
+$7.45M |
ASAN, MTRX, MRVL, VIAV, HIPO
|
13F-HR |
8/14/2024, 03:42 PM |
Q1 2024 |
42 |
$192M |
+$66.9M |
-$53M |
+$13.9M |
HIPO, MTRX, ASAN, AMBA, MRVL
|
13F-HR |
5/15/2024, 03:10 PM |
Q4 2023 |
43 |
$165M |
+$50.2M |
-$36.3M |
+$13.8M |
DOCU, INTC, ANGI, XPER, CSGS
|
13F-HR |
2/14/2024, 02:56 PM |
Q3 2023 |
40 |
$135M |
+$43.3M |
-$48.7M |
-$5.47M |
ASAN, GENI, ANGI, MTRX, CSGS
|
13F-HR |
11/14/2023, 03:04 PM |
Q2 2023 |
43 |
$155M |
+$56.8M |
-$49.6M |
+$7.22M |
ASAN, ANGI, CGNT, GWRE, INTC
|
13F-HR |
8/14/2023, 04:54 PM |
Q1 2023 |
43 |
$139M |
+$40.6M |
-$43.2M |
-$2.64M |
GWRE, ANGI, ASAN, BLKB, HHS
|
13F-HR |
5/15/2023, 03:32 PM |
Q4 2022 |
44 |
$127M |
+$48.6M |
-$33M |
+$15.6M |
BLKB, GWRE, HHS, META, IAC
|
13F-HR |
2/14/2023, 03:04 PM |
Q3 2022 |
41 |
$112M |
+$38.2M |
-$39.3M |
-$1.09M |
ASAN, HHS, BLKB, M103TBA, SCOR
|
13F-HR |
11/14/2022, 05:28 PM |
Q2 2022 |
45 |
$123M |
+$46.9M |
-$46.5M |
+$399K |
HHS, HDSN, META, SCOR, XM
|
13F-HR |
8/15/2022, 04:45 PM |
Q1 2022 |
41 |
$135M |
+$47.9M |
-$56M |
-$8.1M |
HDSN, HHS, INTC, CGNT, GLW
|
13F-HR |
5/16/2022, 04:38 PM |
Q4 2021 |
45 |
$152M |
$0 |
$0 |
|
HDSN, HHS, EVBG, SMAR, BLKB
|
13F-HR |
2/14/2022, 04:18 PM |
Q3 2015 |
41 |
$75.2M |
+$23.2M |
-$18.8M |
+$4.44M |
ATEN, AWAY, MKTO, SYMC, INAP
|
13F-HR |
11/16/2015, 09:38 AM |
Q2 2015 |
41 |
$81.2M |
+$20.2M |
-$26.4M |
-$6.22M |
ATEN, CSOD, AWAY, MKTO, EMC
|
13F-HR |
8/14/2015, 09:23 AM |
Q1 2015 |
38 |
$83.4M |
+$24M |
-$40.3M |
-$16.3M |
IL, INAP, ATEN, MKTO, FEYE
|
13F-HR |
5/15/2015, 08:06 AM |
Q4 2014 |
53 |
$102M |
$0 |
$0 |
|
IL, ESIO, AWAY, FEYE, CSOD
|
13F-HR |
2/17/2015, 09:24 AM |